New York, 23 September 2021 (TDI): Ursula Von der Leyen, President of the European Union, remarked that she is pleased to establish a new collaboration with the United States to help vaccinate the world.
According to President Von der Leyen, the European Union and the United States intend to achieve a global vaccination rate of 70% by the UN General Assembly in 2022. The Global Vaccination Partnership between the European Union and the United States will help to increase supply, enhance delivery coordination, and reduce bottlenecks in supply chains.
The European Union and the United States will collaborate to increase vaccine manufacturing in poor and lower-middle-income nations. The European Union has already invested more than €1 billion in Africa to assist in the spread of mRNA technology. The EU will coordinate its investments in order to establish regional manufacturing facilities.
President Von der Leyen also stated that the EU and the United States will collaborate within the G20 to establish a new Financial Intermediary Fund. It will increase the number of resources available for global health security. She also added that vaccination, production capacity, and finance are all massive challenges, but if we work together, we can overcome them.
Glad to announce a new partnership with the US to help vaccinate the world.
We aim for a 70% global vaccination rate by #UNGA 2022.
The 🇪🇺🇺🇸 Global Vaccination Partnership will help expand supply, improve coordination in delivery and remove bottlenecks to supply chains. pic.twitter.com/6IhYzqvDbe
— Ursula von der Leyen (@vonderleyen) September 22, 2021
By mid-2022, Europe will have shared 500 million doses of vaccine, and every second dose manufactured in the European Union will be exported overseas. At the Global Health Summit, the EU’s industrial partners agreed to supply 1.5 billion doses at a cost to low-income nations in 2021 and 1.5 billion doses in 2022